Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Preoperative Panitumumab and Radiotherapy in Rectal Cancer (PrePaRad)
This study has been terminated.
( The intermediate analyses did not allowed to continue the clinical study. )
Study NCT00973193 Information provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain
First Received on September 7, 2009. Last Updated on July 12, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rectal Cancer
Additional conditions recognized in this trial
Rectal Neoplasms
More general conditions related to this trial
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Interventions listed in this trial
panitumumab
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Back to top of Main Content